ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

Key Findings

• ●ASXL1 and CBL mutations independently predict inferior survival in AdvSM

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

   Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

   tools: pubmed.esummary, crossref.works